To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MARCH7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
517 supporting clones for gene MARCH7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK292836 trachea MARCH7.a 1 to 2402 1 to 2402 exact tiling clone,   2402/2402
(100 %)
1 diff
(100.0 %id)
DC415826 trachea MARCH7.a 1 to 550 1 to 553       551/553
(99 %)
6 diff
(99.0 %id)
DA726194   MARCH7.b 1 to 252 2 to 253   tiling clone, capped   252/252
(100 %)
1 diff
(99.7 %id)
BG723863 testis MARCH7.b 245 to 914 1 to 679   tiling clone,   679/703
(96 %)
19 diff
(97.3 %id)
DA825046 pericardium MARCH7.b 248 to 822 2 to 580   capped   576/579
(99 %)
5 diff
(99.2 %id)
DB459200.
matches multiple genes
testis MARCH7.b 254 to 732 1 to 479     also hits gene LY75andCD302 479/480
(99 %)
2 diff
(99.6 %id)
BP218125 caudate nucleus MARCH7.b 279 to 858 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
BP278286   MARCH7.b 279 to 860 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP290946 lung MARCH7.b 279 to 842 1 to 566       566/583
(97 %)
20 diff
(96.6 %id)
BP352310   MARCH7.b 279 to 860 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA020950   MARCH7.b 280 to 859 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA024291   MARCH7.b 280 to 846 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA220581 brain MARCH7.b 280 to 844 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA294805 hippocampus MARCH7.b 280 to 849 2 to 571   capped   570/571
(99 %)
3 diff
(99.5 %id)
DA317093 hippocampus MARCH7.b 280 to 828 2 to 551   capped   550/550
(100 %)
4 diff
(99.3 %id)
DA448748 tongue, tumor tissue MARCH7.b 280 to 841 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA460806 tongue, tumor tissue MARCH7.b 280 to 859 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB112290 thymus MARCH7.b 280 to 860 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB137590 thymus MARCH7.b 280 to 814 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB240999 trachea MARCH7.b 280 to 867 2 to 589   capped   588/589
(99 %)
1 diff
(99.9 %id)
DB252710 uterus MARCH7.b 280 to 853 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA413335 thalamus MARCH7.b 282 to 835 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA220436 brain MARCH7.b 284 to 841 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB052762 testis MARCH7.b 284 to 835 2 to 554   capped   553/553
(100 %)
5 diff
(99.1 %id)
DA797237 brain MARCH7.b 288 to 827 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
AK022973   MARCH7.b 289 to 3016 1 to 2728 exact available from FLJ,   2728/2728
(100 %)
3 diff
(99.9 %id)
NM_022826.2   MARCH7.b 289 to 3755 1 to 3467 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3467/3467
(100 %)
0 diff
(100 %id)
AU128898   MARCH7.b 290 to 935 2 to 648   capped   647/670
(96 %)
10 diff
(98.6 %id)
CD656384 Embryonic Stem cells MARCH7.b 293 to 1026 12 to 741       730/831
(87 %)
17 diff
(98.0 %id)
CN483858 eye MARCH7.b 295 to 930 1 to 636       636/636
(100 %)
0 diff
(100 %id)
DA460635 tongue, tumor tissue MARCH7.b 296 to 837 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
AK222880 Liver MARCH7.b 297 to 2561 1 to 2265 E376G G379S I412V tiling clone,   2265/2265
(100 %)
4 diff
(99.9 %id)
DA244493 brain MARCH7.b 297 to 892 2 to 597   capped   596/598
(99 %)
2 diff
(99.7 %id)
BP243388 Liver MARCH7.b 297 to 878 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB016153 esophageal, tumor tissue MARCH7.b 297 to 863 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB215624 trachea MARCH7.b 297 to 855 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB019199 esophageal, tumor tissue MARCH7.b 298 to 770 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
DA798844 brain MARCH7.b 300 to 840 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA806611 brain MARCH7.b 300 to 861 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB144103 thymus MARCH7.b 309 to 842 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
DB221494 trachea MARCH7.b 310 to 851 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BX364371   MARCH7.b 313 to 1240 1 to 915       915/957
(95 %)
23 diff
(97.6 %id)
DW417000 Liver MARCH7.b 313 to 602 18 to 307       290/307
(94 %)
7 diff
(97.8 %id)
BC065014 Skin, melanotic melanoma. MARCH7.b 323 to 2944 1 to 2622 exact available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 2622/2622
(100 %)
2 diff
(100.0 %id)
CN484263 eye MARCH7.b 324 to 910 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BU161650 melanotic melanoma, skin MARCH7.b 324 to 1224 1 to 917       917/920
(99 %)
26 diff
(97.2 %id)
DA333287 hippocampus MARCH7.b 398 to 983 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BP363743 lung MARCH7.b 450 to 1031 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP234363 coronary artery MARCH7.b 507 to 1087 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
FN117302 breast carcinoma MARCH7.b 519 to 601 1 to 83       83/83
(100 %)
0 diff
(100 %id)
DB087887 testis MARCH7.b 519 to 1068 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AA970487 pooled MARCH7.b 561 to 967 407 to 1       407/410
(99 %)
2 diff
(99.6 %id)
AW858957 colon MARCH7.b 580 to 727 1 to 148       148/155
(95 %)
4 diff
(97.5 %id)
BG256375 embryonal carcinoma, cell line, testis MARCH7.b 641 to 1299 1 to 655       655/899
(72 %)
10 diff
(98.9 %id)
BF331818 breast MARCH7.b 702 to 924 327 to 104       224/328
(68 %)
0 diff
(100 %id)
EL593409 epidermis, skin MARCH7.b 850 to 1220 397 to 26     Submitted on the opposite strand 372/415
(89 %)
2 diff
(99.6 %id)
EL593428 epidermis, skin MARCH7.b 850 to 1462 15 to 620       606/681
(88 %)
13 diff
(98.1 %id)
DA170409 amygdala MARCH7.b 932 to 1468 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BP259650 heart MARCH7.b 979 to 1512 1 to 535       535/583
(91 %)
21 diff
(96.4 %id)
AA461032   MARCH7.b 993 to 1565 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BG771101 adenocarcinoma, Prostate MARCH7.b 993 to 1633 1 to 643       643/715
(89 %)
9 diff
(98.8 %id)
DA455819 tongue, tumor tissue MARCH7.b 1008 to 1424 2 to 418   capped   417/460
(90 %)
1 diff
(99.8 %id)
BX370804   MARCH7.b 1041 to 1950 19 to 923       905/924
(97 %)
30 diff
(96.8 %id)
EL593435 epidermis, skin MARCH7.b 1042 to 1693 676 to 27     Submitted on the opposite strand 650/680
(95 %)
0 diff
(100 %id)
CN392885 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MARCH7.b 1127 to 1886 8 to 767       760/767
(99 %)
6 diff
(99.3 %id)
BQ278179 ovary, teratocarcinoma, cell line MARCH7.b 1128 to 2023 1 to 900   AAA   900/1064
(84 %)
15 diff
(98.6 %id)
BU849246 ovary, teratocarcinoma, cell line MARCH7.b 1128 to 2023 1 to 904       904/913
(99 %)
15 diff
(98.4 %id)
BP290606 lung MARCH7.b 1131 to 1704 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
DR761545 embryonic stem MARCH7.b 1162 to 1958 1 to 797       797/797
(100 %)
1 diff
(99.9 %id)
CN392890 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MARCH7.b 1173 to 1924 1 to 751   tiling clone,   751/751
(100 %)
2 diff
(99.8 %id)
CN392889 embryonic stem cells, cell lines H1, H7, andH9 MARCH7.b 1215 to 1690 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
AA307375 colon MARCH7.b 1223 to 1500 1 to 278       278/278
(100 %)
0 diff
(100 %id)
AW961150   MARCH7.b 1224 to 1866 1 to 646       646/646
(100 %)
14 diff
(97.9 %id)
BF027589 melanotic melanoma, skin MARCH7.b 1312 to 2088 35 to 808       774/812
(95 %)
13 diff
(98.4 %id)
BF027631 melanotic melanoma, skin MARCH7.b 1312 to 2115 32 to 829       798/876
(91 %)
16 diff
(98.2 %id)
BM552501 leiomyosarcoma, uterus MARCH7.b 1314 to 2109 1 to 805       805/1095
(73 %)
25 diff
(97.8 %id)
CN392886 embryonic stem cells, DMSO-treated H9 cellline MARCH7.b 1317 to 1686 1 to 370       370/370
(100 %)
3 diff
(99.2 %id)
BU181643 eye, retinoblastoma MARCH7.b 1320 to 1856 1 to 548       548/715
(76 %)
44 diff
(93.9 %id)
DA643938   MARCH7.b 1413 to 1939 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
BE812860 amnion_normal MARCH7.b 1421 to 1894 484 to 14       471/486
(96 %)
0 diff
(100 %id)
CV807798 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass MARCH7.b 1421 to 1895 245 to 719       634/719
(88 %)
70 diff
(90.3 %id)
BQ073172 leukocyte MARCH7.b 1437 to 2194 6 to 768       763/1128
(67 %)
22 diff
(98.1 %id)
BE812859 amnion_normal MARCH7.b 1475 to 1898 426 to 4       423/426
(99 %)
0 diff
(100 %id)
BF835286 head_neck MARCH7.b 1489 to 1873 18 to 405       388/405
(95 %)
6 diff
(98.6 %id)
CN392892 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MARCH7.b 1505 to 1795 1 to 291       291/291
(100 %)
3 diff
(99.0 %id)
CK001580 brain/CNS, Bulk tissue from Human Spinal cord MARCH7.b 1516 to 2152 1 to 637       637/637
(100 %)
5 diff
(99.3 %id)
CD639691 pooled MARCH7.b 1528 to 2194 1 to 667       667/702
(95 %)
4 diff
(99.5 %id)
DA463166   MARCH7.b 1529 to 2078 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
FN046450 breast carcinoma MARCH7.b 1535 to 1609 1 to 75       75/76
(98 %)
1 diff
(98.7 %id)
BG542371 lung MARCH7.b 1557 to 2276 1 to 720       720/721
(99 %)
12 diff
(98.4 %id)
BG028684 Bone, osteosarcoma, cell line MARCH7.b 1629 to 2312 1 to 685       685/934
(73 %)
8 diff
(99.2 %id)
BF036881 adenocarcinoma, ovary MARCH7.b 1630 to 2393 1 to 762       762/768
(99 %)
15 diff
(98.1 %id)
AL597638   MARCH7.b 1634 to 2029 1 to 396       396/396
(100 %)
0 diff
(100 %id)
TI_57187614   MARCH7.b 1654 to 2455 54 to 856       803/806
(99 %)
15 diff
(98.2 %id)
BI857310 breast, mammary adenocarcinoma, cell line MARCH7.b 1655 to 2455 1 to 802       802/805
(99 %)
15 diff
(98.2 %id)
BP336149 coronary artery MARCH7.b 1658 to 2240 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP336894 coronary artery MARCH7.b 1658 to 2245 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BP326184 prostata MARCH7.b 1680 to 2259 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BG390249 embryonal carcinoma, cell line, testis MARCH7.b 1689 to 2464 11 to 800       790/910
(86 %)
27 diff
(97.1 %id)
BE167408 head_neck MARCH7.b 1766 to 2081 325 to 10     Submitted on the opposite strand 316/325
(97 %)
4 diff
(98.8 %id)
BC003404 Placenta, choriocarcinoma MARCH7.b 1848 to 3755 1 to 1908   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1908/1908
(100 %)
1 diff
(100.0 %id)
CU456629 epidermis MARCH7.b 1863 to 2644 13 to 794       782/794
(98 %)
8 diff
(99.0 %id)
BE538073 cervix MARCH7.b 1871 to 2466 1 to 610   available from MGC,   608/671
(90 %)
28 diff
(95.9 %id)
BF740722 bocio_tumor MARCH7.b 1890 to 2225 1 to 336       336/336
(100 %)
2 diff
(99.5 %id)
FN083610 breast carcinoma MARCH7.b 1896 to 1988 8 to 98       91/99
(91 %)
4 diff
(96.0 %id)
CK000186 mixed MARCH7.b 1898 to 2676 8 to 788       781/789
(98 %)
11 diff
(98.7 %id)
BM455904 lymph, lymphoma, cell line MARCH7.b 1900 to 2810 1 to 925       925/1085
(85 %)
25 diff
(97.7 %id)
BQ427417 melanotic melanoma, skin MARCH7.b 1901 to 2557 1 to 658       656/918
(71 %)
4 diff
(99.6 %id)
BU165405 eye, retinoblastoma MARCH7.b 1908 to 2770 12 to 876       865/879
(98 %)
14 diff
(98.5 %id)
BG980014 colon_normal MARCH7.b 1922 to 2323 1 to 403       403/403
(100 %)
9 diff
(97.8 %id)
AW995571 breast_normal MARCH7.b 1938 to 2138 14 to 214       201/219
(91 %)
13 diff
(94.1 %id)
BG980031 colon_normal MARCH7.b 1942 to 2330 1 to 390       390/390
(100 %)
10 diff
(97.5 %id)
CB124525 Liver MARCH7.b 1968 to 2556 1 to 589       589/589
(100 %)
0 diff
(100 %id)
Z20457   MARCH7.b 2032 to 2352 1 to 310       313/322
(97 %)
23 diff
(92.9 %id)
AW993450 breast_normal MARCH7.b 2033 to 2595 9 to 570       562/570
(98 %)
6 diff
(99.0 %id)
CD699985 normal nasopharynx MARCH7.b 2049 to 2643 22 to 616       595/616
(96 %)
12 diff
(98.1 %id)
EC452232 Prostate MARCH7.b 2052 to 2136 85 to 1       85/85
(100 %)
0 diff
(100 %id)
BP259574 heart MARCH7.b 2052 to 2632 1 to 581       581/581
(100 %)
0 diff
(100 %id)
N98814 multiple sclerosis lesions MARCH7.b 2064 to 2564 1 to 508       508/510
(99 %)
12 diff
(97.7 %id)
BP290816 lung MARCH7.b 2074 to 2462 1 to 390       390/588
(66 %)
9 diff
(98.5 %id)
BP290804 lung MARCH7.b 2074 to 2462 1 to 390       390/588
(66 %)
9 diff
(98.5 %id)
R19346 whole brain MARCH7.b 2087 to 2417 1 to 345     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 345/363
(95 %)
20 diff
(94.5 %id)
EC531898 Prostate MARCH7.b 2088 to 2184 99 to 2       98/99
(98 %)
0 diff
(100 %id)
BP228107   MARCH7.b 2105 to 2686 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ959357 epidermoid carcinoma, cell line, lung MARCH7.b 2109 to 2967 1 to 860       860/860
(100 %)
2 diff
(99.8 %id)
BG110802 Bone, osteosarcoma, cell line MARCH7.b 2143 to 2744 14 to 618       605/845
(71 %)
16 diff
(98.2 %id)
BG167225 hypernephroma, cell line, Kidney MARCH7.b 2143 to 2649 1 to 518       518/519
(99 %)
12 diff
(97.7 %id)
BG012050 placenta_normal MARCH7.b 2159 to 2609 1 to 452       452/453
(99 %)
7 diff
(98.5 %id)
CN392888 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MARCH7.b 2177 to 2869 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
DB525461 testis MARCH7.b 2183 to 2583 1 to 401   AAA Submitted on the opposite strand 401/401
(100 %)
3 diff
(99.3 %id)
BG621032 placenta MARCH7.b 2205 to 2866 1 to 662       662/816
(81 %)
6 diff
(99.3 %id)
BE161305 head_neck MARCH7.b 2207 to 2407 12 to 212       201/212
(94 %)
6 diff
(97.2 %id)
AW606916 head_neck MARCH7.b 2214 to 2407 1 to 194       194/194
(100 %)
1 diff
(99.5 %id)
AW606918 head_neck MARCH7.b 2214 to 2407 194 to 1       194/194
(100 %)
0 diff
(100 %id)
AW606919 head_neck MARCH7.b 2214 to 2407 1 to 194       194/194
(100 %)
2 diff
(99.0 %id)
AW606921 head_neck MARCH7.b 2214 to 2407 194 to 1       194/194
(100 %)
1 diff
(99.5 %id)
AW606924 head_neck MARCH7.b 2214 to 2407 194 to 1       194/194
(100 %)
2 diff
(99.0 %id)
AW606959 head_neck MARCH7.b 2214 to 2407 1 to 194       194/194
(100 %)
1 diff
(99.5 %id)
AW606974 head_neck MARCH7.b 2214 to 2407 1 to 194       194/194
(100 %)
2 diff
(99.0 %id)
BE161218 head_neck MARCH7.b 2214 to 2407 1 to 194       194/194
(100 %)
2 diff
(99.0 %id)
BE161220 head_neck MARCH7.b 2214 to 2407 1 to 194       194/194
(100 %)
0 diff
(100 %id)
BE161300 head_neck MARCH7.b 2214 to 2419 217 to 11     Submitted on the opposite strand 209/217
(96 %)
0 diff
(100 %id)
AW606927 head_neck MARCH7.b 2222 to 2385 164 to 1       164/174
(94 %)
3 diff
(98.3 %id)
BP339819 Spleen MARCH7.b 2230 to 2786 1 to 556       556/583
(95 %)
6 diff
(99.0 %id)
BG619291 placenta MARCH7.b 2244 to 2898 1 to 659       659/758
(86 %)
13 diff
(98.3 %id)
BG912421 anaplastic oligodendroglioma with 1p/19qloss, brain MARCH7.b 2246 to 2997 1 to 749       749/749
(100 %)
18 diff
(97.6 %id)
CN392887 embryonic stem cells, DMSO-treated H9 cellline MARCH7.b 2276 to 2800 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BX372497   MARCH7.b 2304 to 3157 859 to 1       859/913
(94 %)
12 diff
(98.7 %id)
AA507174 Prostate MARCH7.b 2305 to 2607 311 to 9       303/311
(97 %)
0 diff
(100 %id)
T30104 adrenal gland, Bone MARCH7.b 2322 to 2586 1 to 265       265/272
(97 %)
1 diff
(99.7 %id)
CN391989 embryonic stem cells, cell lines H1, H7, andH9 MARCH7.b 2324 to 3010 1 to 687       687/687
(100 %)
0 diff
(100 %id)
BF792455 adrenal cortex carcinoma, cell line, adrenal gland MARCH7.b 2367 to 3122 1 to 753       753/1008
(74 %)
17 diff
(98.4 %id)
T19434   MARCH7.b 2400 to 2752 1 to 353       353/353
(100 %)
0 diff
(100 %id)
DN915704   MARCH7.b 2429 to 2929 1 to 500       500/500
(100 %)
5 diff
(99.0 %id)
BF697217 brain, primitive neuroectoderm MARCH7.b 2439 to 3028 1 to 585       585/858
(68 %)
11 diff
(98.8 %id)
BG612565 embryonal carcinoma, testis MARCH7.b 2446 to 3129 1 to 683       683/683
(100 %)
5 diff
(99.3 %id)
T33978 blood, white blood cells MARCH7.b 2450 to 2808 1 to 362       362/363
(99 %)
5 diff
(98.7 %id)
BU941128 mixed (pool of 40 RNAs) MARCH7.b 2452 to 3014 1 to 563       563/566
(99 %)
2 diff
(99.7 %id)
AV713613   MARCH7.b 2458 to 3176 1 to 719       719/719
(100 %)
2 diff
(99.8 %id)
AU151119   MARCH7.b 2460 to 3016 556 to 1       556/598
(92 %)
12 diff
(98.0 %id)
BG190281   MARCH7.b 2481 to 3025 58 to 602       545/823
(66 %)
20 diff
(97.6 %id)
BF541667 hypernephroma, Kidney MARCH7.b 2484 to 3129 1 to 645       645/788
(81 %)
17 diff
(97.9 %id)
T34057 blood, white blood cells MARCH7.b 2510 to 2837 1 to 328       328/337
(97 %)
6 diff
(98.3 %id)
T32866 brain MARCH7.b 2522 to 2849 1 to 328       328/328
(100 %)
0 diff
(100 %id)
N66555 multiple sclerosis lesions MARCH7.b 3154 to 3755 604 to 1       604/604
(100 %)
15 diff
(97.6 %id)
DB324379   MARCH7.b 3186 to 3755 570 to 1       570/570
(100 %)
0 diff
(100 %id)
R44621 whole brain MARCH7.b 3375 to 3755 409 to 16   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 394/396
(99 %)
22 diff
(94.5 %id)
BI462287 testis MARCH7.c 1 to 856 1 to 849   tiling clone,   849/1002
(84 %)
34 diff
(96.7 %id)
DC397960 testis MARCH7.c 41 to 606 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
AK310238 testis MARCH7.c 49 to 1437 1 to 1388       1388/1388
(100 %)
4 diff
(99.8 %id)
AK316382 testis MARCH7.c 49 to 2204 1 to 2156 E333G tiling clone,   2156/2156
(100 %)
2 diff
(100.0 %id)
DC395427 testis MARCH7.c 49 to 597 1 to 549       549/549
(100 %)
0 diff
(100 %id)
DC396437 testis MARCH7.c 49 to 626 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
DC399236 testis MARCH7.c 49 to 603 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
AK302347 testis MARCH7.c 57 to 2217 1 to 2161 exact tiling clone,   2161/2161
(100 %)
2 diff
(100.0 %id)
DC399657 testis MARCH7.c 57 to 538 1 to 482       482/482
(100 %)
0 diff
(100 %id)
DC396957 testis MARCH7.c 76 to 643 1 to 568       568/568
(100 %)
5 diff
(99.2 %id)
DC397197 testis MARCH7.c 78 to 645 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
DB460019 testis MARCH7.c 79 to 550 1 to 472       472/472
(100 %)
4 diff
(99.2 %id)
DC396901 testis MARCH7.c 79 to 647 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC397945 testis MARCH7.c 79 to 635 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DC394981 testis MARCH7.c 85 to 644 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
CD244630 testis MARCH7.c 111 to 953 1 to 849       849/863
(98 %)
6 diff
(99.4 %id)
BG527464 lung, mucoepidermoid carcinoma MARCH7.c 2154 to 2880 1 to 731       731/736
(99 %)
14 diff
(98.1 %id)
AW956853   MARCH7.c 2157 to 2797 1 to 649       649/649
(100 %)
29 diff
(95.6 %id)
DA320413 hippocampus MARCH7.c 2164 to 2487 2 to 325   capped   324/324
(100 %)
0 diff
(100 %id)
BG500318 adenocarcinoma, Prostate MARCH7.c 2170 to 2886 1 to 717   tiling clone,   717/718
(99 %)
15 diff
(98.0 %id)
BG896446 cartilage MARCH7.c 2177 to 2505 84 to 413       330/347
(95 %)
6 diff
(98.3 %id)
BF692171 melanotic melanoma, high MDR, skin MARCH7.c 2183 to 2888 1 to 695       695/889
(78 %)
30 diff
(96.7 %id)
BG527259 lung, mucoepidermoid carcinoma MARCH7.c 2219 to 3005 1 to 783       783/804
(97 %)
26 diff
(96.8 %id)
BF679202 Prostate MARCH7.c 2236 to 2887 1 to 647       647/647
(100 %)
12 diff
(98.2 %id)
CD000759 Pooled-Skin MARCH7.c 2253 to 2934 1 to 690       690/776
(88 %)
26 diff
(96.7 %id)
BU194285 bone marrow, from acute myelogenous leukemia MARCH7.c 2265 to 3000 1 to 741       741/798
(92 %)
11 diff
(98.7 %id)
BG493050 lung, mucoepidermoid carcinoma MARCH7.c 2267 to 2756 1 to 496       496/662
(74 %)
21 diff
(96.9 %id)
FN162027 breast carcinoma MARCH7.c 2295 to 2381 1 to 85       85/86
(98 %)
7 diff
(91.9 %id)
AW965379   MARCH7.c 2299 to 2610 1 to 311       311/333
(93 %)
20 diff
(94.0 %id)
BG282962 adenocarcinoma, cell line, Prostate MARCH7.c 2320 to 3092 1 to 763       763/943
(80 %)
26 diff
(97.3 %id)
CA406493 adipose MARCH7.c 2341 to 2960 1 to 619       619/623
(99 %)
2 diff
(99.7 %id)
CB962563 Blood vessels - aorta, basilar and artery MARCH7.c 2347 to 3044 1 to 706       706/745
(94 %)
9 diff
(98.8 %id)
BM762671 lymph node, stomach MARCH7.c 2352 to 3051 1 to 701       701/701
(100 %)
1 diff
(99.9 %id)
CV571214 cornea, eye MARCH7.c 2370 to 2982 1 to 613       613/613
(100 %)
0 diff
(100 %id)
BM468831 embryonal carcinoma, cell line, testis MARCH7.c 2391 to 2991 1 to 601       601/1066
(56 %)
1 diff
(100.0 %id)
AV687439 hepatocellular carcinoma MARCH7.c 2394 to 2899 1 to 502       502/514
(97 %)
3 diff
(99.5 %id)
AW023401 cochlea, ear MARCH7.c 2396 to 2957 8 to 569       562/569
(98 %)
6 diff
(99.0 %id)
BX364370   MARCH7.c 2401 to 3351 949 to 3       947/956
(99 %)
0 diff
(100 %id)
BG028433 Bone, osteosarcoma, cell line MARCH7.c 2459 to 3182 8 to 723       716/972
(73 %)
30 diff
(97.0 %id)
BX089417 placenta MARCH7.c 2464 to 3160 1 to 697       697/697
(100 %)
2 diff
(99.8 %id)
R80039 placenta MARCH7.c 2464 to 2828 1 to 380       380/402
(94 %)
21 diff
(94.8 %id)
H12566 placenta MARCH7.c 2464 to 2764 1 to 302       302/302
(100 %)
2 diff
(99.4 %id)
BQ214944 melanotic melanoma, skin MARCH7.c 2467 to 3000 16 to 550       535/1061
(50 %)
44 diff
(95.9 %id)
TI_149300613   MARCH7.c 2486 to 3391 972 to 84   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 889/969
(91 %)
15 diff
(98.5 %id)
BG572636 placenta MARCH7.c 2489 to 3388 1 to 903       903/905
(99 %)
21 diff
(97.7 %id)
BG289452 bladder, transitional cell papilloma, cell line MARCH7.c 2498 to 2658 1 to 161   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 161/162
(99 %)
1 diff
(99.4 %id)
TI_154048182   MARCH7.c 2514 to 3389 961 to 96   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 866/991
(87 %)
18 diff
(98.2 %id)
FN101366 breast carcinoma MARCH7.c 2538 to 2589 1 to 53       53/54
(98 %)
4 diff
(92.6 %id)
AA127294 uterus MARCH7.c 2555 to 2971 1 to 418       418/418
(100 %)
3 diff
(99.3 %id)
AI420008 pooled MARCH7.c 2567 to 3052 488 to 3       486/488
(99 %)
0 diff
(100 %id)
CB163036 Liver MARCH7.c 2578 to 3159 30 to 611       582/612
(95 %)
1 diff
(99.9 %id)
BM471562 leiomyosarcoma, uterus MARCH7.c 2587 to 3394 1 to 813       813/1165
(69 %)
18 diff
(98.5 %id)
AA056165 uterus MARCH7.c 2593 to 3056 1 to 464     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 464/464
(100 %)
1 diff
(99.8 %id)
AA147493 uterus MARCH7.c 2598 to 2930 1 to 334       334/334
(100 %)
2 diff
(99.5 %id)
AW151845 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MARCH7.c 2601 to 3039 439 to 1       439/439
(100 %)
0 diff
(100 %id)
BE537175 cervix MARCH7.c 2621 to 3140 86 to 607       522/607
(85 %)
6 diff
(99.1 %id)
BM976650 lung, Primary Lung Cystic Fibrosis EpithelialCells MARCH7.c 2661 to 3391 747 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 731/731
(100 %)
2 diff
(99.8 %id)
BQ435577 testis MARCH7.c 2666 to 3387 1 to 721   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 721/723
(99 %)
7 diff
(99.1 %id)
CA432130 cell lines, Enchondroma MARCH7.c 2678 to 3389 730 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 712/716
(99 %)
1 diff
(99.9 %id)
BG566754 Liver MARCH7.c 2685 to 3396 1 to 709       709/727
(97 %)
6 diff
(99.2 %id)
TI_149304176   MARCH7.c 2688 to 3389 788 to 87   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 702/702
(100 %)
0 diff
(100 %id)
BM982036 lung, Primary Lung Cystic Fibrosis EpithelialCells MARCH7.c 2709 to 3389 699 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 681/681
(100 %)
0 diff
(100 %id)
TI_154020639   MARCH7.c 2715 to 3389 761 to 87   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 675/677
(99 %)
2 diff
(99.8 %id)
CB241397 Human Lung Epithelial cells, lung MARCH7.c 2719 to 3391 689 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 673/673
(100 %)
0 diff
(100 %id)
AA514941 breast MARCH7.c 2731 to 3037 307 to 1       307/307
(100 %)
1 diff
(99.7 %id)
DN919096   MARCH7.c 2732 to 3280 1 to 549       549/552
(99 %)
2 diff
(99.7 %id)
R66635 placenta MARCH7.c 2739 to 3044 1 to 307   fully sequenced,   307/307
(100 %)
2 diff
(99.4 %id)
BU172500 melanotic melanoma, skin MARCH7.c 2739 to 3389 1 to 651   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 651/651
(100 %)
0 diff
(100 %id)
CA438584 lung, Metastatic Chondrosarcoma MARCH7.c 2765 to 3389 643 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 625/625
(100 %)
0 diff
(100 %id)
TI_149273004   MARCH7.c 2788 to 3394 724 to 118       607/956
(63 %)
0 diff
(100 %id)
CN391988 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MARCH7.c 2792 to 3391 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BU675474 lung, Primary Lung Epithelial Cells MARCH7.c 2793 to 3394 622 to 21       602/622
(96 %)
0 diff
(100 %id)
H02116 placenta MARCH7.c 2800 to 3079 1 to 284   fully sequenced,   284/284
(100 %)
5 diff
(98.3 %id)
R24209 placenta MARCH7.c 2807 to 3132 1 to 336       336/360
(93 %)
19 diff
(94.8 %id)
R35562 placenta MARCH7.c 2811 to 3050 1 to 244   fully sequenced,   244/244
(100 %)
8 diff
(96.8 %id)
R76871 placenta MARCH7.c 2811 to 3097 1 to 295   fully sequenced,   295/295
(100 %)
3 diff
(99.0 %id)
AI478160 Kidney MARCH7.c 2817 to 3389 573 to 1       573/573
(100 %)
0 diff
(100 %id)
AI742915 pooled MARCH7.c 2863 to 3388 526 to 1       526/526
(100 %)
0 diff
(100 %id)
BQ631959 Pancreas, Purified pancreatic islet MARCH7.c 2873 to 3389 1 to 518       518/518
(100 %)
5 diff
(99.1 %id)
AI811241 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus MARCH7.c 2895 to 3389 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
AI433431 Kidney MARCH7.c 2896 to 3389 505 to 12   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 494/494
(100 %)
1 diff
(99.8 %id)
H12567 placenta MARCH7.c 2897 to 3389 507 to 1       507/507
(100 %)
30 diff
(94.1 %id)
AI346531 adenocarcinoma, colon MARCH7.c 2901 to 3390 490 to 1       490/490
(100 %)
0 diff
(100 %id)
TI_158435759   MARCH7.c 2902 to 3389 588 to 89   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 500/629
(79 %)
25 diff
(96.1 %id)
AW070802 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary MARCH7.c 2914 to 3395 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AW664414 2 pooled high-grade transitional celltumors, genitourinary tract MARCH7.c 2916 to 3400 485 to 1   tiling clone,   485/485
(100 %)
0 diff
(100 %id)
AA223515 brain, neuroepithelial cells MARCH7.c 2917 to 3391 477 to 2       476/477
(99 %)
0 diff
(100 %id)
AI075953 pooled MARCH7.c 2918 to 3388 471 to 1       471/471
(100 %)
0 diff
(100 %id)
CN484644 eye MARCH7.c 2919 to 3389 1 to 471   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
AI818245 adenocarcinoma, Pancreas MARCH7.c 2921 to 3390 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
AI635138 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MARCH7.c 2923 to 3390 474 to 7       468/474
(98 %)
0 diff
(100 %id)
AI470125 pooled MARCH7.c 2926 to 3390 467 to 3       465/467
(99 %)
0 diff
(100 %id)
AI452649 pooled MARCH7.c 2928 to 3388 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AI889179 serous papillary carcinoma, high grade, 2pooled tumors, uterus MARCH7.c 2930 to 3390 469 to 9       461/469
(98 %)
0 diff
(100 %id)
AI015796   MARCH7.c 2931 to 3390 468 to 9       460/468
(98 %)
0 diff
(100 %id)
TI_153995428   MARCH7.c 2931 to 3389 578 to 118       461/1200
(38 %)
0 diff
(100 %id)
AI492361 Kidney MARCH7.c 2937 to 3390 461 to 6       456/461
(98 %)
0 diff
(100 %id)
AW628073 2 pooled high-grade transitional celltumors, genitourinary tract MARCH7.c 2938 to 3389 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AW023282 cochlea, ear MARCH7.c 2939 to 3354 1 to 416       416/416
(100 %)
5 diff
(98.8 %id)
AW292836   MARCH7.c 2941 to 3389 467 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
AW151039 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MARCH7.c 2945 to 3391 453 to 7       447/453
(98 %)
0 diff
(100 %id)
BE047682 brain, tumor, 5 pooled (see description) MARCH7.c 2947 to 3400 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
AW301609 Kidney MARCH7.c 2955 to 3395 448 to 7       442/448
(98 %)
0 diff
(100 %id)
AI798170 pooled MARCH7.c 2960 to 3390 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
AI610685 serous papillary carcinoma, high grade, 2pooled tumors, uterus MARCH7.c 2968 to 3390 427 to 5       423/427
(99 %)
0 diff
(100 %id)
AA644549 lung, lung carcinoma MARCH7.c 2974 to 3395 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AI138505 placenta MARCH7.c 2981 to 3395 419 to 5       415/419
(99 %)
0 diff
(100 %id)
AI309539 adenocarcinoma, colon MARCH7.c 2982 to 3389 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI375265 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MARCH7.c 2983 to 3390 416 to 9       408/416
(98 %)
0 diff
(100 %id)
AA126863 uterus MARCH7.c 2989 to 3389 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AI924423 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MARCH7.c 2998 to 3390 398 to 6       393/398
(98 %)
0 diff
(100 %id)
AI803016 pooled MARCH7.c 3002 to 3395 399 to 7       393/399
(98 %)
0 diff
(100 %id)
FN049288 breast carcinoma MARCH7.c 3010 to 3130 1 to 121       121/121
(100 %)
1 diff
(99.2 %id)
R67357 placenta MARCH7.c 3014 to 3389 385 to 1   fully sequenced,   385/385
(100 %)
16 diff
(95.9 %id)
BF438895 pooled MARCH7.c 3020 to 3388 369 to 1       369/369
(100 %)
0 diff
(100 %id)
BF055971 pooled MARCH7.c 3022 to 3394 389 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 373/373
(100 %)
1 diff
(99.8 %id)
AA580468 colon, colon tumor MARCH7.c 3035 to 3390 362 to 7       356/362
(98 %)
0 diff
(100 %id)
AW468587 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood MARCH7.c 3045 to 3400 357 to 2       356/357
(99 %)
0 diff
(100 %id)
R34235 placenta MARCH7.c 3049 to 3390 356 to 1   fully sequenced,   356/356
(100 %)
22 diff
(93.9 %id)
R79946 placenta MARCH7.c 3049 to 3362 318 to 1       318/319
(99 %)
5 diff
(98.5 %id)
H02016 placenta MARCH7.c 3049 to 3389 352 to 1   fully sequenced,   352/352
(100 %)
15 diff
(95.8 %id)
AI926754 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MARCH7.c 3056 to 3390 341 to 7       335/341
(98 %)
0 diff
(100 %id)
FN055478 breast carcinoma MARCH7.c 3058 to 3161 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BF507718   MARCH7.c 3062 to 3389 346 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 329/329
(100 %)
3 diff
(99.1 %id)
AI282772 colon, moderately-differentiated adenocarcinoma MARCH7.c 3064 to 3389 326 to 1       326/326
(100 %)
0 diff
(100 %id)
N55836   MARCH7.c 3066 to 3325 1 to 257       257/257
(100 %)
9 diff
(96.5 %id)
R76872 placenta MARCH7.c 3067 to 3366 311 to 1   fully sequenced,   311/311
(100 %)
10 diff
(96.8 %id)
AA767752 germinal center B cell MARCH7.c 3097 to 3389 316 to 24   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 293/293
(100 %)
0 diff
(100 %id)
N63088 multiple sclerosis lesions MARCH7.c 3099 to 3395 306 to 10       297/307
(96 %)
0 diff
(100 %id)
BE045313 lymph node, lymphoma, follicular mixed small and largecell MARCH7.c 3104 to 3389 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AI473093 Kidney MARCH7.c 3106 to 3390 287 to 2       286/287
(99 %)
0 diff
(100 %id)
FN116403 breast carcinoma MARCH7.c 3132 to 3231 1 to 98       98/98
(100 %)
4 diff
(96.0 %id)
AI718143 aorta MARCH7.c 3138 to 3390 255 to 3       253/255
(99 %)
0 diff
(100 %id)
FN053406 breast carcinoma MARCH7.c 3144 to 3250 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
AA046405 uterus MARCH7.c 3144 to 3389 265 to 20   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 246/246
(100 %)
0 diff
(100 %id)
AI932575 adenocarcinoma, Pancreas MARCH7.c 3167 to 3394 227 to 1       227/231
(98 %)
6 diff
(97.5 %id)
AW150533 serous papillary carcinoma, high grade, 2pooled tumors, uterus MARCH7.c 3192 to 3390 203 to 5       199/203
(98 %)
0 diff
(100 %id)
BU564600 mixed (pool of 40 RNAs) MARCH7.c 3198 to 3375 1 to 178       178/205
(86 %)
3 diff
(98.6 %id)
DV460443 cochlea, ear MARCH7.c 3217 to 3377 1 to 161       161/161
(100 %)
4 diff
(97.6 %id)
AA027358 heart MARCH7.c 3241 to 3392 152 to 1       152/158
(96 %)
0 diff
(100 %id)
FN062032 breast carcinoma MARCH7.c 3271 to 3383 1 to 115       115/115
(100 %)
2 diff
(98.3 %id)
GD145962   MARCH7.c 3295 to 3389 1 to 95   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 95/95
(100 %)
2 diff
(97.9 %id)
GD147213   MARCH7.c 3295 to 3389 1 to 95   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 95/95
(100 %)
1 diff
(99.0 %id)
DA809802 brain MARCH7.d 1 to 587 2 to 588   tiling clone, capped   587/587
(100 %)
2 diff
(99.7 %id)
DC320475 brain MARCH7.d 3 to 558 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
DC320703 brain MARCH7.d 3 to 535 1 to 540       540/548
(98 %)
9 diff
(98.4 %id)
DC332826 hippocampus MARCH7.d 3 to 533 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
DC342332 thalamus MARCH7.d 3 to 549 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
BP250855 hippocampus MARCH7.d 3 to 586 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
DC296467 synovial membrane tissue from rheumatioidarthritis MARCH7.d 3 to 552 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BP350271 brain MARCH7.d 3 to 584 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC393944 esophageal, tumor tissue MARCH7.d 3 to 565 1 to 563       563/565
(99 %)
3 diff
(99.5 %id)
BP365361 lung MARCH7.d 3 to 589 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
DC411989 kidney, tumor tissue MARCH7.d 3 to 560 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
DA234222 brain MARCH7.d 4 to 581 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DA237401 brain MARCH7.d 4 to 589 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA410661 thalamus MARCH7.d 4 to 677 2 to 676   capped   675/675
(100 %)
1 diff
(99.9 %id)
DC400807 testis MARCH7.d 5 to 541 1 to 540       540/540
(100 %)
3 diff
(99.5 %id)
BP315130 mammary gland MARCH7.d 7 to 598 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
CD700058 normal nasopharynx MARCH7.d 12 to 424 22 to 434       413/434
(95 %)
7 diff
(98.4 %id)
DW423814 Liver MARCH7.d 13 to 293 10 to 290       281/290
(96 %)
6 diff
(98.0 %id)
AV739569 cord Blood MARCH7.d 16 to 535 42 to 550       509/597
(85 %)
18 diff
(97.0 %id)
BX480761   MARCH7.d 16 to 165 1 to 150       150/151
(99 %)
1 diff
(99.4 %id)
DA737988   MARCH7.d 17 to 802 2 to 782   tiling clone, capped   781/833
(93 %)
6 diff
(99.3 %id)
DA248078 brain MARCH7.d 21 to 618 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA510598 brain MARCH7.d 21 to 597 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DC428361   MARCH7.d 21 to 518 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BP310201 brain MARCH7.d 21 to 602 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP310307 brain MARCH7.d 21 to 603 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA224357 brain MARCH7.d 22 to 581 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB084783 testis MARCH7.d 22 to 590 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DC401356 testis MARCH7.d 23 to 556 1 to 536       536/536
(100 %)
2 diff
(99.7 %id)
BP363846 lung MARCH7.d 24 to 610 1 to 587       587/587
(100 %)
8 diff
(98.7 %id)
DA233747 brain MARCH7.d 25 to 604 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
DA317596 hippocampus MARCH7.d 25 to 580 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA677283   MARCH7.d 25 to 613 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA854426 placenta MARCH7.d 32 to 628 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DC332942 hippocampus MARCH7.d 33 to 472 1 to 444       444/444
(100 %)
5 diff
(98.9 %id)
BP228871 brain MARCH7.d 33 to 616 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP228894 brain MARCH7.d 33 to 616 1 to 585       585/585
(100 %)
19 diff
(96.8 %id)
BP231057 brain MARCH7.d 33 to 614 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AU280060   MARCH7.d 33 to 573 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
DA853412 placenta MARCH7.d 34 to 598 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BQ423829 eye, retinoblastoma MARCH7.d 37 to 848 12 to 827   tiling clone,   816/899
(90 %)
40 diff
(95.6 %id)
DN994504 brain, whole brain MARCH7.d 38 to 633 1 to 597       597/597
(100 %)
6 diff
(99.0 %id)
DB476747.
matches multiple genes
hippocampus MARCH7.d 39 to 535 1 to 497     also hits gene LY75andCD302 497/497
(100 %)
5 diff
(99.0 %id)
DB150264 thymus MARCH7.d 40 to 596 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA093555 cerebellum MARCH7.d 41 to 683 2 to 644   capped   643/643
(100 %)
1 diff
(99.9 %id)
DA437434 tongue, tumor tissue MARCH7.d 41 to 571 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA990055 synovial membrane tissue from rheumatioidarthritis MARCH7.d 41 to 575 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB292549 uterus MARCH7.d 43 to 622 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BP359178 mammary gland MARCH7.d 48 to 630 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB144637 thymus MARCH7.d 59 to 599 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BU172197 melanotic melanoma, skin MARCH7.d 64 to 830 1 to 773   tiling clone,   773/945
(81 %)
17 diff
(98.3 %id)
CD691020 normal nasopharynx MARCH7.d 69 to 568 71 to 574       504/574
(87 %)
13 diff
(97.8 %id)
CN392891 embryonic stem cells, DMSO-treated H9 cellline MARCH7.d 70 to 406 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
DA307046 hippocampus MARCH7.d 84 to 662 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
CD690892 normal nasopharynx MARCH7.d 85 to 671 23 to 609       587/609
(96 %)
7 diff
(98.9 %id)
BP336471 coronary artery MARCH7.d 85 to 665 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP364959 lung MARCH7.d 85 to 687 1 to 603       603/603
(100 %)
9 diff
(98.6 %id)
DA031242   MARCH7.d 86 to 671 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA032027   MARCH7.d 86 to 640 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA458489 tongue, tumor tissue MARCH7.d 86 to 673 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
BP235874 coronary artery MARCH7.d 86 to 668 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
DA771256 brain MARCH7.d 86 to 646 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP313738 mammary gland MARCH7.d 86 to 670 1 to 583       583/583
(100 %)
8 diff
(98.7 %id)
BP314237 mammary gland MARCH7.d 86 to 671 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
DA858751 placenta MARCH7.d 86 to 657 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BP337300 coronary artery MARCH7.d 86 to 667 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DB125652 thymus MARCH7.d 86 to 645 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB281819 uterus MARCH7.d 86 to 625 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA889913   MARCH7.d 96 to 650 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BP337424 coronary artery MARCH7.d 98 to 680 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BI020190 marrow MARCH7.d 101 to 600 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
AL833651 lymph node MARCH7.d 1025 to 3559 1 to 2535   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2535/2535
(100 %)
1 diff
(100.0 %id)
DB370603   MARCH7.d 2970 to 3557 586 to 1       586/586
(100 %)
30 diff
(94.9 %id)
AK299051   MARCH7.e 1 to 2370 1 to 2370 G323S tiling clone,   2370/2370
(100 %)
2 diff
(100.0 %id)
DC369375   MARCH7.e 1 to 559 1 to 559       559/559
(100 %)
0 diff
(100 %id)
DC377988 brain MARCH7.e 1 to 564 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BP315308 mammary gland MARCH7.e 1 to 478 1 to 476       476/582
(81 %)
8 diff
(98.7 %id)
DC400751 testis MARCH7.e 1 to 438 1 to 503       448/503
(89 %)
10 diff
(98.1 %id)
DC415872 trachea MARCH7.e 1 to 461 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
BM453417 melanotic melanoma, skin MARCH7.e 336 to 1180 1 to 848       848/921
(92 %)
8 diff
(99.2 %id)
AU128592   MARCH7.e 1032 to 1638 2 to 610   tiling clone, capped   609/609
(100 %)
8 diff
(98.7 %id)
W07055 lung MARCH7.e 1376 to 1870 1 to 503       503/591
(85 %)
19 diff
(96.8 %id)
AL050171 uterus MARCH7.e 1790 to 3260 1 to 1472   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1472/1472
(100 %)
1 diff
(100.0 %id)
W77921 heart MARCH7.e 1798 to 2230 1 to 434       434/434
(100 %)
3 diff
(99.4 %id)
W93772 heart MARCH7.e 1798 to 2084 1 to 286       286/286
(100 %)
1 diff
(99.7 %id)
W72742 heart MARCH7.e 2675 to 3265 599 to 1   tiling clone,   599/601
(99 %)
19 diff
(96.9 %id)
W93656 heart MARCH7.e 2705 to 3265 566 to 1       566/568
(99 %)
15 diff
(97.4 %id)
DB365769   MARCH7.e 2722 to 3262 541 to 1       541/548
(98 %)
7 diff
(98.8 %id)
N78774 lung MARCH7.e 2863 to 3271 410 to 1   tiling clone,   410/410
(100 %)
1 diff
(99.8 %id)
CR975386 T-Lymphocytes MARCH7.f 1 to 821 1 to 821 R243X E253X R254X Q259X T273X tiling clone,   821/821
(100 %)
0 diff
(100 %id)
BP216304 corpus callosum MARCH7.f 50 to 629 1 to 582       580/582
(99 %)
8 diff
(98.7 %id)
DC416111 trachea MARCH7.g 1 to 551 4 to 554   tiling clone,   554/554
(100 %)
2 diff
(99.7 %id)
BE926625 breast MARCH7.g 536 to 894 1 to 361   tiling clone,   361/365
(98 %)
15 diff
(95.9 %id)
BE080812 breast MARCH7.g 547 to 858 310 to 1   tiling clone, Submitted on the opposite strand 310/310
(100 %)
3 diff
(99.1 %id)
BF338893 brain, glioblastoma with EGFR amplification MARCH7.g 873 to 1556 1 to 679   tiling clone,   679/918
(73 %)
28 diff
(97.0 %id)
AL707498 human skeletal muscle MARCH7.g 1177 to 1751 7 to 581       575/581
(98 %)
6 diff
(99.0 %id)
BX643883   MARCH7.g 1179 to 1883 1 to 705   tiling clone,   705/705
(100 %)
1 diff
(99.9 %id)
BX508824   MARCH7.h-u 1 to 701 1 to 701   tiling clone,   701/701
(100 %)
9 diff
(98.8 %id)
AL704995 human skeletal muscle MARCH7.h-u 254 to 894 1 to 642   tiling clone,   642/642
(100 %)
1 diff
(99.9 %id)
BF096086 uterus_tumor MARCH7.h-u 477 to 825 10 to 359       350/375
(93 %)
13 diff
(96.6 %id)
BF096254 uterus_tumor MARCH7.h-u 477 to 825 10 to 359       350/375
(93 %)
13 diff
(96.6 %id)
AL700778 human skeletal muscle MARCH7.h-u 485 to 948 1 to 466       466/466
(100 %)
7 diff
(98.5 %id)
AK124225 thymus MARCH7.h-u 524 to 4519 1 to 3995   tiling clone, available from FLJ,   3995/3995
(100 %)
5 diff
(99.9 %id)
DB130647 thymus MARCH7.h-u 525 to 980 2 to 458   capped   457/457
(100 %)
1 diff
(99.8 %id)
AL706667 human skeletal muscle MARCH7.h-u 637 to 1126 1 to 490   tiling clone,   490/494
(99 %)
1 diff
(99.8 %id)
CN285421 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MARCH7.h-u 670 to 949 1 to 282       282/282
(100 %)
6 diff
(97.9 %id)
AW183565 pooled MARCH7.h-u 794 to 1100 1 to 308     Submitted on the opposite strand 308/308
(100 %)
1 diff
(99.7 %id)
DB141729 thymus MARCH7.h-u 906 to 1165 2 to 261   capped   260/264
(98 %)
2 diff
(99.3 %id)
CR627026 fetal kidney MARCH7.h-u 908 to 4515 1 to 3610   tiling clone, available from DKFZ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3610/3628
(99 %)
7 diff
(99.9 %id)
TI_149282794   MARCH7.h-u 1141 to 1871 1 to 728     Submitted on the opposite strand 728/729
(99 %)
14 diff
(98.1 %id)
BM971415 lung, Primary Lung Epithelial Cells MARCH7.h-u 1146 to 1822 1 to 672     Submitted on the opposite strand 672/672
(100 %)
7 diff
(99.0 %id)
TI_149304820   MARCH7.h-u 1149 to 2026 67 to 930     Submitted on the opposite strand 864/1069
(80 %)
18 diff
(98.4 %id)
CN371530 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MARCH7.h-u 1182 to 1801 1 to 620       620/620
(100 %)
2 diff
(99.7 %id)
DA109071 cerebellum MARCH7.h-u 1186 to 1770 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BX504869   MARCH7.h-u 1342 to 2034 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
CN371531 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MARCH7.h-u 1439 to 1859 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BY995394   MARCH7.h-u 1447 to 2123 1 to 677   tiling clone,   677/677
(100 %)
1 diff
(99.9 %id)
DA277106 corpus callosum MARCH7.h-u 1558 to 2129 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
CD513044 brain, Pituitary MARCH7.h-u 1887 to 2656 1 to 779       779/873
(89 %)
22 diff
(97.5 %id)
BX484529   MARCH7.h-u 1929 to 2623 1 to 695       695/695
(100 %)
6 diff
(99.2 %id)
BI772240 pooled lung and spleen MARCH7.h-u 2032 to 2637 1 to 607       607/607
(100 %)
6 diff
(99.1 %id)
TI_57180014   MARCH7.h-u 2032 to 2637 29 to 635       607/635
(95 %)
6 diff
(99.1 %id)
DB178639 kidney, tumor tissue MARCH7.h-u 2278 to 2832 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
Z43815 brain, total brain MARCH7.h-u 2340 to 2672 1 to 333       333/333
(100 %)
0 diff
(100 %id)
F11941 brain, total brain MARCH7.h-u 2340 to 2696 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
T65088 whole brain MARCH7.h-u 2365 to 2688 1 to 331       331/432
(76 %)
7 diff
(98.4 %id)
R20069 whole brain MARCH7.h-u 2365 to 2715 1 to 356       356/364
(97 %)
6 diff
(98.4 %id)
DA250273 caudate nucleus MARCH7.h-u 2445 to 3002 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BF372709 prostate_tumor MARCH7.h-u 2468 to 2722 11 to 263       253/276
(91 %)
8 diff
(97.2 %id)
DA829761 placenta MARCH7.h-u 2518 to 3234 2 to 722   capped   721/755
(95 %)
7 diff
(99.1 %id)
AA056675 uterus MARCH7.h-u 2520 to 2780 1 to 265       265/312
(84 %)
5 diff
(98.4 %id)
CB178400 Pancreas, Purified pancreatic islet MARCH7.h-u 2529 to 3042 10 to 523     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 514/523
(98 %)
6 diff
(98.9 %id)
BJ990825 hepatoblastoma MARCH7.h-u 2549 to 3137 12 to 600       589/600
(98 %)
6 diff
(99.0 %id)
BM147509 leukopheresis MARCH7.h-u 2713 to 3237 1 to 523       523/524
(99 %)
3 diff
(99.5 %id)
BM149365 leukopheresis MARCH7.h-u 2713 to 3047 1 to 335       335/339
(98 %)
1 diff
(99.8 %id)
BM149965 leukopheresis MARCH7.h-u 2713 to 3233 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
BM150173 leukopheresis MARCH7.h-u 2713 to 3031 1 to 320       320/326
(98 %)
14 diff
(95.8 %id)
W32689 heart MARCH7.h-u 2756 to 3072 1 to 339   fully sequenced,   339/339
(100 %)
9 diff
(97.4 %id)
AA454968 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MARCH7.h-u 2823 to 3375 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
AA136390 lung, lung carcinoma MARCH7.h-u 2993 to 3060 1 to 68       68/68
(100 %)
0 diff
(100 %id)
W20438 heart MARCH7.h-u 3042 to 3353 314 to 1   fully sequenced,   314/314
(100 %)
0 diff
(100 %id)
AA333674   MARCH7.h-u 3101 to 3352 1 to 252       252/252
(100 %)
0 diff
(100 %id)
AA334519   MARCH7.h-u 3101 to 3421 1 to 323       323/329
(98 %)
3 diff
(99.1 %id)
DB307228 corpus callosum MARCH7.h-u 3177 to 3723 548 to 1       548/548
(100 %)
2 diff
(99.7 %id)
CV573087 cornea, eye MARCH7.h-u 3209 to 3752 1 to 544       544/544
(100 %)
0 diff
(100 %id)
F09587 brain, total brain MARCH7.h-u 3456 to 3703 249 to 2       248/249
(99 %)
0 diff
(100 %id)
Z39883 brain, total brain MARCH7.h-u 3468 to 3703 236 to 1       236/236
(100 %)
1 diff
(99.6 %id)
BJ990826 hepatoblastoma MARCH7.h-u 3953 to 4492 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB344548 thymus MARCH7.h-u 3997 to 4519 525 to 1       525/525
(100 %)
2 diff
(99.7 %id)
DB374684 placenta MARCH7.h-u 4008 to 4514 506 to 1       506/537
(94 %)
8 diff
(98.6 %id)
AA056552 uterus MARCH7.h-u 4014 to 4519 509 to 1       509/509
(100 %)
4 diff
(99.3 %id)
AA454969 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MARCH7.h-u 4035 to 4514 480 to 1       480/480
(100 %)
0 diff
(100 %id)
CB178642 Pancreas, Purified pancreatic islet MARCH7.h-u 4058 to 4520 472 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 463/472
(98 %)
0 diff
(100 %id)
DA527837 brain MARCH7.h-u 4181 to 4734 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA863708 placenta MARCH7.h-u 4415 to 4993 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DB517723.
matches multiple genes
testis MARCH7.h-u 4572 to 5024 474 to 22     also hits gene LY75andCD302 453/474
(95 %)
0 diff
(100 %id)
DB520086.
matches multiple genes
testis MARCH7.h-u 4572 to 5020 449 to 1     also hits gene LY75andCD302 449/449
(100 %)
0 diff
(100 %id)
DB520913.
matches multiple genes
testis MARCH7.h-u 4572 to 5028 457 to 1     also hits gene LY75andCD302 457/457
(100 %)
0 diff
(100 %id)
DB526403.
matches multiple genes
testis MARCH7.h-u 4572 to 5017 446 to 1     also hits gene LY75andCD302 446/446
(100 %)
0 diff
(100 %id)
BM144264 leukopheresis MARCH7.h-u 4572 to 5034 18 to 480   AAA   463/484
(95 %)
3 diff
(99.4 %id)
DB552702.
matches multiple genes
hippocampus MARCH7.h-u 4574 to 5041 468 to 1     also hits gene LY75andCD302 468/470
(99 %)
2 diff
(99.6 %id)
DA959843 Spleen MARCH7.h-u 4696 to 5248 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
AW936133 denis_drash MARCH7.h-u 4784 to 5265 1 to 482       482/484
(99 %)
4 diff
(99.2 %id)
DB523174.
matches multiple genes
testis MARCH7.h-u 4796 to 5250 455 to 1     also hits gene LY75andCD302 455/456
(99 %)
1 diff
(99.8 %id)
DA684424   MARCH7.h-u 4814 to 5351 2 to 540   tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
DA331012 hippocampus MARCH7.h-u 4846 to 5420 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
AI536015 Prostate MARCH7.h-u 4880 to 5270 422 to 28       395/440
(89 %)
0 diff
(100 %id)
BM990616 lung, Lung Focal Fibrosis MARCH7.h-u 5053 to 5648 598 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 595/598
(99 %)
0 diff
(100 %id)
DA380162 thalamus MARCH7.h-u 5062 to 5613 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
BE710149 head_neck MARCH7.h-u 5520 to 5910 1 to 393       393/393
(100 %)
2 diff
(99.5 %id)
AW948781 prostate_tumor MARCH7.h-u 5526 to 5888 1 to 362       362/362
(100 %)
8 diff
(97.8 %id)
BE768220 prostate_tumor MARCH7.h-u 5527 to 5949 2 to 426   tiling clone,   425/426
(99 %)
9 diff
(97.9 %id)
BQ329706 lung_normal MARCH7.h-u 5586 to 5992 1 to 408       408/409
(99 %)
9 diff
(97.8 %id)
AW369098 head_neck MARCH7.h-u 5713 to 6131 10 to 425       416/425
(97 %)
6 diff
(98.6 %id)
BE768192 prostate_tumor MARCH7.h-u 5717 to 5983 1 to 266       266/266
(100 %)
2 diff
(99.3 %id)
AW377821 head_neck MARCH7.h-u 5742 to 6131 1 to 389       389/389
(100 %)
8 diff
(98.0 %id)
AK126410 uterus MARCH7.h-u 5912 to 8459 1 to 2548 exact tiling clone, available from FLJ,   2548/2548
(100 %)
4 diff
(99.9 %id)
DB263119 uterus MARCH7.h-u 5913 to 6507 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
CN307020 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MARCH7.h-u 6038 to 6644 1 to 606 exact     606/606
(100 %)
5 diff
(99.2 %id)
TI_151808657   MARCH7.h-u 6149 to 6968 79 to 896 exact tiling clone, fully sequenced, AAA   818/818
(100 %)
7 diff
(99.2 %id)
AW377822 head_neck MARCH7.h-u 6150 to 6380 1 to 229       229/232
(98 %)
7 diff
(97.0 %id)
CK301062 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MARCH7.h-u 6209 to 6968 778 to 19 F4X AAA   760/764
(99 %)
5 diff
(99.4 %id)
BG500153 adenocarcinoma, Prostate MARCH7.h-u 6256 to 6954 1 to 696 Y21H C32*     696/864
(80 %)
8 diff
(99.1 %id)
AI692567 carcinoid, lung MARCH7.h-u 6417 to 6967 551 to 1       551/551
(100 %)
2 diff
(99.7 %id)
AI685209 adenocarcinoma, Pancreas MARCH7.h-u 6470 to 6960 493 to 3       491/493
(99 %)
0 diff
(100 %id)
AI824329 carcinoid, lung MARCH7.h-u 6545 to 6969 428 to 4       425/428
(99 %)
0 diff
(100 %id)
CB160697 Liver MARCH7.h-u 6585 to 7085 34 to 534       501/534
(93 %)
6 diff
(98.9 %id)
H92318 eye, retina MARCH7.h-u 6608 to 6928 331 to 1       331/355
(93 %)
16 diff
(95.5 %id)
AW341306 carcinoid, lung MARCH7.h-u 6649 to 6967 319 to 1       319/319
(100 %)
1 diff
(99.7 %id)
AV649872 corresponding non cancerous liver tissue MARCH7.h-u 6731 to 7106 377 to 1       377/377
(100 %)
7 diff
(98.2 %id)
AV649890 corresponding non cancerous liver tissue MARCH7.h-u 6735 to 7106 373 to 1       373/375
(99 %)
7 diff
(98.2 %id)
BM144408 leukopheresis MARCH7.h-u 6838 to 7268 5 to 435   AAA   431/435
(99 %)
6 diff
(98.7 %id)
BM148610 leukopheresis MARCH7.h-u 6838 to 7124 5 to 291       287/292
(98 %)
15 diff
(94.9 %id)
FN077712 breast carcinoma MARCH7.h-u 6846 to 6970 1 to 124       124/124
(100 %)
1 diff
(99.2 %id)
BE242549 leukopheresis MARCH7.h-u 6850 to 7122 1 to 273       273/273
(100 %)
5 diff
(98.2 %id)
TI_151732248   MARCH7.h-u 6893 to 6976 153 to 74   fully sequenced,   80/153
(52 %)
6 diff
(96.1 %id)
DB351723 uterus MARCH7.h-u 7939 to 8459 521 to 1       521/521
(100 %)
0 diff
(100 %id)
BF375411 stomach MARCH7.h-u 8231 to 8508 1 to 279   tiling clone,   279/279
(100 %)
6 diff
(97.9 %id)
AK023400 ovary, tumor tissue MARCH7.i-u 1 to 1849 2 to 1848   tiling clone, available from FLJ,   1848/1848
(100 %)
16 diff
(99.2 %id)
AU134399 ovary, tumor tissue MARCH7.i-u 1 to 774 2 to 775   capped   774/777
(99 %)
24 diff
(97.0 %id)
H72069 liver and spleen MARCH7.i-u 167 to 562 399 to 1   tiling clone,   399/399
(100 %)
9 diff
(97.8 %id)
BQ432938 testis MARCH7.i-u 295 to 957 1 to 676   tiling clone,   676/757
(89 %)
19 diff
(97.5 %id)
BU853999 testis MARCH7.i-u 295 to 1063 1 to 783   tiling clone,   783/789
(99 %)
24 diff
(97.0 %id)
AW809572 stomach MARCH7.i-u 539 to 946 1 to 417   tiling clone,   417/419
(99 %)
32 diff
(92.4 %id)
FN163182 breast carcinoma MARCH7.i-u 993 to 1089 95 to 1   tiling clone, Submitted on the opposite strand 95/95
(100 %)
2 diff
(97.9 %id)
BX112937   MARCH7.i-u 1077 to 1684 1 to 607   tiling clone,   607/607
(100 %)
1 diff
(99.9 %id)
AA447310 Prostate MARCH7.i-u 1078 to 1568 12 to 501       490/501
(97 %)
6 diff
(98.9 %id)
AA374560 lung MARCH7.i-u 1222 to 1544 1 to 324       324/324
(100 %)
7 diff
(97.9 %id)
AU155401 ovary, tumor tissue MARCH7.i-u 1275 to 1849 574 to 1       574/580
(98 %)
14 diff
(97.6 %id)
BQ020823 lung, Metastatic Chondrosarcoma MARCH7.i-u 1321 to 1867 546 to 1   tiling clone,   546/546
(100 %)
2 diff
(99.7 %id)
AW051404 brain, glioblastoma (pooled) MARCH7.i-u 1366 to 1849 484 to 1       484/484
(100 %)
0 diff
(100 %id)
DB373471 placenta MARCH7.i-u 1385 to 1849 464 to 1       464/464
(100 %)
12 diff
(97.5 %id)
AI027620   MARCH7.i-u 1399 to 1854 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
AW118469 brain, tumor, 5 pooled (see description) MARCH7.i-u 1568 to 1853 284 to 1       284/285
(99 %)
2 diff
(99.3 %id)
DA897874 skeletal muscle MARCH7.i-u 1600 to 2165 2 to 567 exact tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
N42489 melanocyte MARCH7.i-u 2050 to 2343 1 to 302   tiling clone,   302/310
(97 %)
11 diff
(96.5 %id)
AI275522 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MARCH7.i-u 2369 to 2828 467 to 8   tiling clone,   460/467
(98 %)
0 diff
(100 %id)
N31820 melanocyte MARCH7.i-u 2374 to 2889 541 to 30       512/644
(79 %)
0 diff
(100 %id)
AI264044 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MARCH7.i-u 2446 to 2889 474 to 31   tiling clone,   444/474
(93 %)
0 diff
(100 %id)
H97798 melanocyte MARCH7.i-u 2478 to 2889 441 to 29       413/443
(93 %)
0 diff
(100 %id)
AI263420 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MARCH7.i-u 2484 to 2889 436 to 31       406/438
(92 %)
0 diff
(100 %id)
N35050 melanocyte MARCH7.i-u 2491 to 2889 428 to 29       400/432
(92 %)
0 diff
(100 %id)
BX101119 melanocyte MARCH7.j-u 1 to 600 1 to 601 exact     601/612
(98 %)
3 diff
(99.6 %id)
AF086110   MARCH7.j-u 1 to 746 1 to 746 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 746/746
(100 %)
2 diff
(99.8 %id)
W02884 melanocyte MARCH7.j-u 33 to 555 1 to 546 exact     546/550
(99 %)
27 diff
(95.1 %id)
N72288 melanocyte MARCH7.j-u 268 to 746 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
BE882901 leiomyosarcoma, uterus MARCH7.k 1 to 594 1 to 600 A76S R77T S78L R79K S80D ... tiling clone,   600/985
(60 %)
11 diff
(98.9 %id)
DC351776 brain MARCH7.l 1 to 558 2 to 563 exact tiling clone,   563/563
(100 %)
5 diff
(99.2 %id)
AW063959 thymus MARCH7.m-u -8 to 385 1 to 394 I2R Q3P tiling clone,   394/396
(99 %)
6 diff
(98.5 %id)
AL698895 human skeletal muscle MARCH7.n-u 1 to 237 1 to 237 exact tiling clone,   237/237
(100 %)
0 diff
(100 %id)
AW813517 stomach MARCH7.o 1 to 233 1 to 242 E2I S3G K4V P5* tiling clone,   221/242
(91 %)
12 diff
(95.1 %id)
DB306005 brain Gene MARCH7, variant not shown              
DA243357 brain Gene MARCH7, variant not shown       capped      
AV654469 corresponding non cancerous liver tissue Gene MARCH7, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
H37984 liver and spleen Gene MARCH7, variant not shown         This clone was ignored    
H38205 liver and spleen Gene MARCH7, variant not shown         This clone was ignored    
AI309207 2 pooled tumors (clear cell type), Kidney Gene MARCH7, variant not shown         This clone was ignored    
AI682745 adenocarcinoma, Pancreas Gene MARCH7, variant not shown       AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS    
BP283501 bone marrow Gene MARCH7, variant not shown         Suspected internal deletion, this clone was ignored    
DC408023 thymus Gene MARCH7, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j-u, .k, .l, .m-u, .n-u, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI